CSL Behring Achieves European Milestone with First Real-World Treatments of Hemophilia B Using HEMGENIX® Gene Therapy

Global biotechnology leader CSL Behring  announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dez...

July 04, 2024 | Thursday | News
Vertex Pharmaceuticals' Vanza Triple Granted Priority Review by FDA with Target Action Date of January 2, 2025

Vanza triple granted priority review with Prescription Drug User Fee Act (PDUFA) target action date of January 2, 2025 – - EU Marketing Authorizat...

July 03, 2024 | Wednesday | News
Hofseth BioCare ASA Transfers Eosinophil-Targeting Drug Candidate MA-022a to Subsidiary HBC Immunology Inc

Hofseth BioCare ASA ("HBC" or the "Company"), a global leader in marine lipid and peptide research,  announces the decision to transfer its eosinoph...

July 02, 2024 | Tuesday | News
Valneva's Single-Dose Chikungunya Vaccine, IXCHIQ®, Receives European Commission Approval

  Valneva SE , a specialty vaccine company, today announced that the European Commission (EC) has granted marketing authorization in Europe for Val...

July 01, 2024 | Monday | News
Dawn Health Partners with Merck to Develop Digital Solution for Growth Hormone Disorders

Dawn Health, the digital health company pioneering patient-first innovation, has announced they are working with leading global pharmaceutical company, M...

July 01, 2024 | Monday | News
WHO Awards Prequalification to Roche's HPV Test for Broad Use, Enhancing Global Cervical Cancer Screening

The World Health Organization (WHO) has awarded Roche's human papillomavirus (HPV) test prequalification designations for use on the cobas 5800 System ...

June 27, 2024 | Thursday | News
Merck Celebrates 100th Anniversary in Spain

Merck, a leading science and technology company, is proud to announce the celebration of its 100th anniversary in Spain. Since opening our first commercial...

June 27, 2024 | Thursday | News
Regulatory Review Begins for Bavarian Nordic's Single-Dose Chikungunya Vaccine in EU and U.S.

Regulatory review of the single-dose CHIKV VLP vaccine candidate for immunization to prevent disease caused by chikungunya virus infection in individua...

June 26, 2024 | Wednesday | News
ANEW Medical Explores Pioneering Therapeutics and Diagnostics with Secreted Klotho Proteins

ANEW to explore therapeutics and specialty diagnostics utilizing the s-KL protein and will pursue other medical product development and commercial oppo...

June 26, 2024 | Wednesday | News
BioNTech and DualityBio's ADC Candidate BNT324/DB-1311 Gains FDA Fast-Track Status for Prostate Cancer

The status is based on preclinical data and data from an ongoing phase 1/2 study for BNT324/DB-1311; preliminary phase 1/2 clinical data showed anti-tu...

June 25, 2024 | Tuesday | News
Roche Introduces cobas® c 703 and cobas® ISE neo for Streamlined Lab Operations

The cobas® c 703 and cobas® ISE neo analytical units, deliver higher testing capacity and increased automation helping to improve laboratory wo...

June 24, 2024 | Monday | News
FDA Clears EG 427’s EG110A for Clinical Trials in Neurogenic Bladder Disorder

EG110A to start Phase 1b/2a clinical study in Neurogenic Detrusor Overactivity (NDO) patients NDO is a severe bladder condition affecting millions of ...

June 24, 2024 | Monday | News
WACKER and CordenPharma Consortium Enters Pandemic Readiness State to Produce 80 Million Vaccine Doses Annually

    • Consortium formed between WACKER & CordenPharma has officially entered the pandemic readiness state as of 1 June 2024 to produ...

June 21, 2024 | Friday | News
Roche Launches First Clinically Approved ISH Test for Comprehensive B-Cell Lymphoma Diagnosis

The VENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail assay is the first clinically approved in-situ hybridisation (ISH) test with the sensitivity ...

June 20, 2024 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close